Carmell Therapeutics Corporation (CTCX)
USD 0.23
(0.13%)
USD 0.23
(0.13%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -8.34 Million | -3.42 Million | -1.17 Million |
| Net Income | -15.44 Million | -9.05 Million | -6.47 Million |
| Depreciation & Amortization | 124.78 Thousand | 242.55 Thousand | 242.12 Thousand |
| Deferred income taxes | 9.44 Million | -194.59 Thousand | 2.51 Million |
| Stock-based compensation | 667.68 Thousand | 636.36 Thousand | 246.79 Thousand |
| Change in working capital | -3.42 Million | 2.33 Million | 952.68 Thousand |
| Other non-cash items | 285.51 Thousand | 2.59 Million | 1.34 Million |
| Investing Cash Flow | -30.47 Thousand | -7164.00 | -7273.00 |
| Investments in PPE | -30.47 Thousand | -7164.00 | -7273.00 |
| Acquisitions | - | - | - |
| Investment purchases | - | - | -154.44 Million |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | 154.44 Million |
| Financing Cash Flow | 11.16 Million | 3.55 Million | 1.19 Million |
| Debt repayment | -3.2 Million | -2.74 Million | -1.12 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | -2294.00 | - |
| Common Stock Issuance | 41.07 Thousand | -97.78 Thousand | 3194.00 |
| Other Financing Activities | 12.46 Million | 3.65 Million | 1.19 Million |
| Accounts receivables | -204.55 Thousand | - | - |
| Accounts payables | -449.87 Thousand | 1.05 Million | 80.32 Thousand |
| Inventory | 204.55 Thousand | - | - |
| Other working capital | -2.97 Million | 1.27 Million | 872.36 Thousand |
| Cash at beginning of period | 128.14 Thousand | 12.36 Thousand | 1150.00 |
| Cash at end of period | 2.91 Million | 128.14 Thousand | 12.36 Thousand |
| Capital Expenditure | -30.47 Thousand | -7164.00 | -7273.00 |
| Effect of forex changes on cash | - | -702.31 Thousand | 762.98 Thousand |
| Net cash flow / Change in cash | 2.78 Million | 115.78 Thousand | 11.21 Thousand |
| Free Cash Flow | -8.37 Million | -3.43 Million | -1.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.3 Million | -3.55 Million | 3.15 Million | -15.44 Million | -19.49 Million | 317.51 Thousand |
| Depreciation & Amortization | 58.27 Thousand | 57.57 Thousand | -349.38 Thousand | 124.78 Thousand | 423.8 Thousand | 62.08 Thousand |
| Deferred income taxes | - | - | -324.31 Thousand | 9.44 Million | - | - |
| Stock-based compensation | 163.7 Thousand | 211.46 Thousand | 62.38 Thousand | 667.68 Thousand | 237.76 Thousand | 187.03 Thousand |
| Change in working capital | -185.46 Thousand | 1.29 Million | -5.66 Million | -3.42 Million | -228.75 Thousand | 1.54 Million |
| Other non-cash items | 2.59 Million | 1.37 Million | -25.05 Thousand | 285.51 Thousand | 14.27 Million | -1.86 Million |
| Investing Cash Flow | - | -748.79 Thousand | -662.99 Thousand | -30.47 Thousand | 632.52 Thousand | -30.47 Thousand |
| Investments in PPE | -4.00 | - | - | -30.47 Thousand | -30.47 Thousand | - |
| Acquisitions | - | -748.79 Thousand | - | - | 662.99 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.44 Million | -195.72 Thousand | -1.24 Million | 11.16 Million | 12.41 Million | -375 Thousand |
| Debt repayment | -211.09 Thousand | -227.26 Thousand | -108.04 Thousand | -3.2 Million | -3.09 Million | -473.5 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.68 Million | - | - | 41.07 Thousand | 41.06 Thousand | - |
| Other Financing Activities | -31.53 Thousand | 31.53 Thousand | -803.43 Thousand | 12.46 Million | 15.46 Million | - |
| Accounts receivables | - | - | - | -204.55 Thousand | - | - |
| Accounts payables | -188.05 Thousand | -133.76 Thousand | 1.01 Million | -449.87 Thousand | -3.02 Million | 1.39 Million |
| Inventory | - | - | - | 204.55 Thousand | 1.6 Million | - |
| Other working capital | 116.45 Thousand | 1.42 Million | -6.67 Million | -2.97 Million | 2.79 Million | 1.54 Million |
| Cash at beginning of period | 892.16 Thousand | 7.96 Million | 7.96 Million | 128.14 Thousand | 10.24 Thousand | 16.13 Thousand |
| Cash at end of period | 2.19 Million | 892.16 Thousand | 2.91 Million | 2.91 Million | 7.96 Million | 10.24 Thousand |
| Capital Expenditure | -4.00 | - | - | -30.47 Thousand | -30.47 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | -59.51 Thousand | - |
| Net cash flow / Change in cash | 1.3 Million | -7.07 Million | -5.05 Million | 2.78 Million | 7.95 Million | -5890.00 |
| Free Cash Flow | -1.13 Million | -1.07 Million | -3.14 Million | -8.37 Million | -5.05 Million | -5890.00 |
BGAVF
NUGN
SCP
CLPHF
SIEGY
BBXIA